TAKE ACTION NOW!
Use this form to send an email to Congress
H.R.3648: Gluten in Medication Disclosure Act of 2015
Celiac Disease Foundation urges you to contact your local Member of House and ask them to co-sponsor H.R. 3648: Gluten in Medicine Disclosure Act of 2015.
With FDA labeling requirements for gluten-free foods now secured, Celiac Disease Foundation is pleased to support Representatives Tim Ryan (OH-13) and Nita Lowey’s (NY-17) Gluten in Medicine Disclosure Act. The celiac disease community should be able to take both prescription and non-prescription medicines with as much confidence as possible that it will improve our quality of life. Without this legislation, that confidence is missing.
What is H.R.3648: Gluten in Medication Disclosure Act of 2015
Representatives Tim Ryan (OH-13) and Nita Lowey (NY-17) introduced the H.R.3648: Gluten in Medication Disclosure Act of 2015, first in 2012, which makes it easier to identify gluten in pharmaceutical products. This legislation requires that drug labels contain a statement identifying the source of any ingredient constituting or derived from a grain or starch-containing ingredient.
According to the Mayo Clinic, celiac disease is four times more common now than 60 years ago. The Food Allergen Labeling Consumer Protection Act of 2004 required packaged food labels to identify all ingredients containing wheat and other allergens, but this important distinction is missing from medication labels. The lack of information regarding gluten in medicine is hazardous for celiac disease patients.
Click here to view the full press release.